Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Safer injection for neck pain? study tests new Ultrasound-Guided method

NCT ID NCT07275320

Symptom relief Sponsor: Istanbul Medeniyet University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two injection treatments for neck pain caused by cervical radiculopathy. Seventy adults who did not get better with standard care were randomly assigned to receive either an ultrasound-guided retrolaminar block or a fluoroscopy-guided epidural injection. The goal was to see which method provides better pain relief and safety over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine and steroid injection
What this could lead to
If successful, this could show that a safer, ultrasound-guided injection works as well as the standard fluoroscopy-guided method for neck pain relief.
What could go wrong
This is a small, completed study with only 70 participants, so results may not apply to everyone. The new technique may not be as effective as the standard one.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

70 people

The number who actually took part.

Started

Dec 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with a diagnosis of cervical radiculopathy confirmed by magnetic resonance imaging (MRI). * Visual Analog Scale (VAS) pain score ≥ 5 and an elevated Neck Disability Index (NDI) score. * Age between 18 and 80 years. * Patients without motor weakness or clinical signs of myelopathy. * Patients who did not respond to conservative treatments such as analgesics, physical therapy, or traction. Exclusion Criteria: * Patients who do not provide informed consent or who have coagulopathy. * Patients with a known allergy to the study medications, organ failure, pregnancy, or lactation. * Patients with infection in the cervical spine or surrounding tissues, or those with rheumatologic, neurologic, or neuromuscular diseases. * Patients with a history of cervical spine surgery or with shoulder/peripheral nerve pathology that may confound the diagnosis. * Patients using neuropathic pain medications (such as pregabalin or gabapentin) or those with a cardiac pacemaker.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical radiculopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

radiculopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical radiculopathy

Contacts and locations

Locations

  • Goztepe Suleyman Yalcin City Hospital, Department of Anesthesiology and Reanimation, Interventional Pain Management Unit

    Istanbul, Kadikoy, Istanbul, 34722, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.